JP2023529216A - Apol1の阻害剤及びその使用 - Google Patents
Apol1の阻害剤及びその使用 Download PDFInfo
- Publication number
- JP2023529216A JP2023529216A JP2022575988A JP2022575988A JP2023529216A JP 2023529216 A JP2023529216 A JP 2023529216A JP 2022575988 A JP2022575988 A JP 2022575988A JP 2022575988 A JP2022575988 A JP 2022575988A JP 2023529216 A JP2023529216 A JP 2023529216A
- Authority
- JP
- Japan
- Prior art keywords
- groups
- branched
- optionally substituted
- hydroxy
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063038276P | 2020-06-12 | 2020-06-12 | |
| US63/038,276 | 2020-06-12 | ||
| PCT/US2021/036944 WO2021252849A1 (en) | 2020-06-12 | 2021-06-11 | Inhibitors of apol1 and use of the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023529216A true JP2023529216A (ja) | 2023-07-07 |
| JP2023529216A5 JP2023529216A5 (cg-RX-API-DMAC7.html) | 2024-06-17 |
Family
ID=76797122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022575988A Pending JP2023529216A (ja) | 2020-06-12 | 2021-06-11 | Apol1の阻害剤及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230014907A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4165023A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023529216A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115867532A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021286666A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3185144A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021252849A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3897833T (lt) | 2018-12-17 | 2026-04-27 | Vertex Pharmaceuticals Incorporated | Apol1 inhibitoriai ir jų panaudojimo būdai |
| EP4097083A1 (en) | 2020-01-29 | 2022-12-07 | Vertex Pharmaceuticals Incorporated | Inhibitors of apol1 and methods of using same |
| EP4114385A1 (en) | 2020-03-06 | 2023-01-11 | Vertex Pharmaceuticals Incorporated | Methods of treating apol-1 dependent focal segmental glomerulosclerosis |
| EP4146633A4 (en) | 2020-05-07 | 2024-09-25 | Rambam Med-Tech Ltd. | COMPOSITION FOR USE IN THE TREATMENT OF A DISEASE ASSOCIATED WITH APOL1 |
| JP2023530271A (ja) | 2020-06-12 | 2023-07-14 | バーテックス ファーマシューティカルズ インコーポレイテッド | Apol1の阻害剤及びこれを使用する方法 |
| CN115867543A (zh) | 2020-06-12 | 2023-03-28 | 弗特克斯药品有限公司 | Apol1抑制剂的固体形式及其使用方法 |
| BR112023003423A2 (pt) | 2020-08-26 | 2023-03-21 | Vertex Pharma | Inibidores de apol1 e métodos de uso destes |
| US12612379B2 (en) | 2021-11-30 | 2026-04-28 | Vertex Pharmaceuticals Incorporated | Inhibitors of APOL1 and methods of using same |
| CA3244229A1 (en) * | 2021-12-24 | 2023-06-29 | Psylo Pty Ltd | COMPOUNDS |
| MX2024008868A (es) | 2022-01-18 | 2024-09-23 | Maze Therapeutics Inc | Inhibidores de la apolipoproteína l1 (apol1) y métodos de uso. |
| WO2023154314A1 (en) * | 2022-02-08 | 2023-08-17 | Vertex Pharmaceuticals Incorporated | Spiro piperidine derivatives as inhibitors of apol1 and methods of using same |
| EP4476228A1 (en) * | 2022-02-08 | 2024-12-18 | Vertex Pharmaceuticals Incorporated | 4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran] derivatives as inhibitors of apol1 and methods of using same |
| EP4476199A1 (en) * | 2022-02-08 | 2024-12-18 | Vertex Pharmaceuticals Incorporated | 2-methyl-4-phenylpiperidin-4-ol derivatives as inhibitors of apol1 and methods of using same |
| WO2024220852A2 (en) * | 2023-04-20 | 2024-10-24 | University Of Florida Research Foundation, Incorporated | Tead core inhibitors for cancer therapeutics |
| EP4705296A1 (en) * | 2023-05-03 | 2026-03-11 | OmniAB, Inc. | Heteroarylindole inhibitors of apol-1 |
| CN116789603A (zh) * | 2023-06-06 | 2023-09-22 | 南昌大学 | 一种新型多菌灵半抗原、全抗原、抗体及其制备方法及应用 |
| WO2025042797A1 (en) * | 2023-08-18 | 2025-02-27 | Shattuck Labs, Inc. | Trim7 inhibitors and uses thereof |
| GB202401326D0 (en) * | 2024-02-01 | 2024-03-20 | Podium Bio Ltd | Novel compounds |
| WO2025231011A1 (en) * | 2024-05-01 | 2025-11-06 | Omniab, Inc. | Heteroarylindole inhibitors of apol-1 |
| TW202613098A (zh) * | 2024-07-09 | 2026-04-01 | 大陸商上海旭成醫藥科技有限公司 | 一種APOLs抑制劑 |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06501030A (ja) * | 1991-06-27 | 1994-01-27 | フィディーアージョージタウン・インスティテュート・フォア・ザ・ニューロサイエンシーズ | 神経系および精神系不調を処置するためのインドール誘導体、医薬組成物および方法 |
| WO2000051984A1 (en) * | 1999-03-04 | 2000-09-08 | Merck Sharp & Dohme Limited | 2-aryl indole derivatives as antagonists of tachykinins |
| US20010039286A1 (en) * | 2000-02-14 | 2001-11-08 | Kevin Dinnell | 2-aryl indole derivatives and their use as therapeutic agents |
| JP2001526286A (ja) * | 1997-12-19 | 2001-12-18 | イーライ・リリー・アンド・カンパニー | 低血糖性イミダゾリン化合物 |
| JP2009516742A (ja) * | 2005-11-22 | 2009-04-23 | メルク エンド カムパニー インコーポレーテッド | インドールオレキシン受容体アンタゴニスト |
| JP7573528B2 (ja) * | 2018-12-17 | 2024-10-25 | バーテックス ファーマシューティカルズ インコーポレイテッド | Apol1の阻害剤及びその使用方法 |
| JP7668804B2 (ja) * | 2020-01-29 | 2025-04-25 | バーテックス ファーマシューティカルズ インコーポレイテッド | Apol1の阻害剤およびこれを使用する方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2801585B1 (fr) * | 1999-11-25 | 2002-02-15 | Fournier Ind & Sante | Nouveaux antagonistes des recepteurs de l'ii-8 |
| WO2002028831A1 (en) * | 2000-10-02 | 2002-04-11 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
| FR2824827B1 (fr) * | 2001-05-17 | 2004-02-13 | Fournier Lab Sa | Nouveaux derives de 5-phenyl-1h-indole antagoniste des recepteurs de l'interleukine-8 |
| FR2824826B1 (fr) * | 2001-05-17 | 2003-11-07 | Fournier Lab Sa | Nouveaux derives de 5-cyano-1h-indole antagonistes des recepteurs de l'interleukine-8 |
| JP5107589B2 (ja) * | 2007-02-13 | 2012-12-26 | 旭化成株式会社 | インドール誘導体 |
| EP2178870B1 (en) * | 2007-08-17 | 2018-09-19 | LG Chem, Ltd. | Indole and indazole compounds as an inhibitor of cellular necrosis |
| WO2016029310A1 (en) * | 2014-08-27 | 2016-03-03 | The Governing Council Of The University Of Toronto | Cannabinoid type 1 receptor modulators |
-
2021
- 2021-06-11 US US17/345,256 patent/US20230014907A1/en active Pending
- 2021-06-11 CA CA3185144A patent/CA3185144A1/en active Pending
- 2021-06-11 EP EP21737887.6A patent/EP4165023A1/en not_active Withdrawn
- 2021-06-11 CN CN202180049447.6A patent/CN115867532A/zh active Pending
- 2021-06-11 JP JP2022575988A patent/JP2023529216A/ja active Pending
- 2021-06-11 AU AU2021286666A patent/AU2021286666A1/en not_active Abandoned
- 2021-06-11 WO PCT/US2021/036944 patent/WO2021252849A1/en not_active Ceased
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06501030A (ja) * | 1991-06-27 | 1994-01-27 | フィディーアージョージタウン・インスティテュート・フォア・ザ・ニューロサイエンシーズ | 神経系および精神系不調を処置するためのインドール誘導体、医薬組成物および方法 |
| JP2001526286A (ja) * | 1997-12-19 | 2001-12-18 | イーライ・リリー・アンド・カンパニー | 低血糖性イミダゾリン化合物 |
| WO2000051984A1 (en) * | 1999-03-04 | 2000-09-08 | Merck Sharp & Dohme Limited | 2-aryl indole derivatives as antagonists of tachykinins |
| US20010039286A1 (en) * | 2000-02-14 | 2001-11-08 | Kevin Dinnell | 2-aryl indole derivatives and their use as therapeutic agents |
| JP2009516742A (ja) * | 2005-11-22 | 2009-04-23 | メルク エンド カムパニー インコーポレーテッド | インドールオレキシン受容体アンタゴニスト |
| JP7573528B2 (ja) * | 2018-12-17 | 2024-10-25 | バーテックス ファーマシューティカルズ インコーポレイテッド | Apol1の阻害剤及びその使用方法 |
| JP7668804B2 (ja) * | 2020-01-29 | 2025-04-25 | バーテックス ファーマシューティカルズ インコーポレイテッド | Apol1の阻害剤およびこれを使用する方法 |
Non-Patent Citations (2)
| Title |
|---|
| REGISTRY(STN)[ONLINE],[検索日 2025.05.06],, JPN6025021197, 15 May 2019 (2019-05-15), ISSN: 0005602042 * |
| SHAW, D., ET.AL, JOURNAL OF MEDICINAL CHEMISTRY, vol. 36, no. 20, JPN6025021198, 1993, pages 2908 - 20, ISSN: 0005602041 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2021286666A1 (en) | 2023-01-19 |
| CN115867532A (zh) | 2023-03-28 |
| CA3185144A1 (en) | 2021-12-16 |
| WO2021252849A1 (en) | 2021-12-16 |
| EP4165023A1 (en) | 2023-04-19 |
| US20230014907A1 (en) | 2023-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2021286666A1 (en) | Inhibitors of APOL1 and use of the same | |
| US20250042878A1 (en) | Inhibitors of apol1 and methods of using same | |
| JP7668804B2 (ja) | Apol1の阻害剤およびこれを使用する方法 | |
| US12281102B2 (en) | Inhibitors of APOL1 and methods of using same | |
| JP7733670B2 (ja) | アルファ1-アンチトリプシンのモジュレーター | |
| WO2021203010A1 (en) | Pyrrolo[2,3-f]indazole and 2,4,5,10-tetrazatricyclo[7.3.0.03,7]dodeca-1,3(7),5,8,11-pentaene derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd) | |
| EP4126881A1 (en) | Pyrano[4,3-b]l ndole derivatives as alpha-1 -antitrypsin modulators for treating alpha-1 -antitrypsin deficiency (aatd) | |
| JP2005529954A (ja) | 化学プロセス |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240607 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240607 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250526 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20250529 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20251114 |